Perkinelmer (PKI) 51.69 $PKI
18.0% Return Seen to Date on SmarTrend PerkinElmer Call (PKI)
Comtex SmarTrend(R) - Wed Apr 22, 9:59AM CDT
SmarTrend identified an Uptrend for PerkinElmer (NYSE
KI) on December 19th, 2014 at $43.81. In approximately 4 months, PerkinElmer has returned 18.02% as of today's recent price of $51.70.
PKI: 51.69 (-0.02)
My Top Life Sciences Tools And Services Stocks For 2015
Stan Stafford - at Seeking Alpha - Wed Apr 22, 12:57AM CDT
PRXL: 67.12 (-0.42), Q: 66.45 (-0.25), CBM: 42.07 (-0.65), TMO: 130.69 (-3.75), NEO: 4.83 (-0.04), ILMN: 190.04 (-9.27), LMNX: 16.34 (-0.01), CRL: 78.06 (-0.53), PKI: 51.69 (-0.02), ICLR: 69.24 (+1.28), MTD: 324.14 (+0.66)
Lab Automation Markets: Key Companies, Forecasts and Trends, 2015 Edition - Sample Transport, Specimen Handling, Plate Readers, Storage & Retrieval, Robotics, LIMS
M2 - Tue Apr 21, 4:04AM CDT
Research and Markets (http://www.researchandmarkets.com/research/bdct5v/lab_automation) has announced the addition of the "Lab Automation Markets, 4th Edition (Systems [Sample Transport, Specimen Handling, Plate Readers, Storage & Retrieval, Robotics, LIMS], Key Companies, Forecasts and Trends)" report to their offering. Automation is influencing health care, especially in clinical diagnostic and drug company laboratories where systems are improving work flow and adding speed and efficiency. Over the years, many laboratories in North America, Europe and elsewhere have installed fully functional automation systems, as well as individual automated systems. Lab Automation Markets, 4th Edition, analyzes the current and potential world markets for medical laboratory automation systems and equipment - both for the clinical diagnostics lab and the drug discovery and research laboratory. This report generally offers forecasts future growth to 2017. Market segments covered include: - Sample transport systems - Specimen and liquid handling systems - Storage and retrieval systems - Work stations - Plate readers - Robotics - Dissolution testing - Laboratory information management systems This report gives insight into issues facing the industry and also reviews the nature and the direction of research and trends in automation equipment, including: - Miniaturization - Connectivity - Consolidation - Integration - Analytical intelligence - Robotics As automation companies seek to find new market opportunities and increase their sales, several of these firms have inked partnership agreements or have established other types of collaborative arrangements with in vitro diagnostic (IVD) companies. For automation suppliers, these arrangements can lead to sales that might otherwise not been achieved without the attraction of the IVD systems. Partnerships discussed include: - Roche-PVT - Pfizer-UCB - BD-Kiestra - Tecan-Recipe - Singulex-Tecan - Copan-MetaSystems - Quanterix-Stratec - Beckman Coulter Life Sciences-New England Biolabs - Beckman Coulter-IRIS Diagnostics - Beckman Coulter Life Sciences-Illumina - Brooks Automation-FluidX - Molecular Devices-Roche - bioM?rieux-Copan - Roche-Hitachi Market forecasts are based on an examination of current market conditions and on investigations into the development of new products by key companies. The report profiles companies involved in developing and marketing medical laboratory automation systems and equipment: - Abbott Diagnostics - Accel Biotech - Agilent Technologies Inc. - Ai Scientific - Analytik Jena - Andrew Alliance - Apricot Designs - Astech Projects Ltd. - Aurora Biotechnologies - Brooks Automation Inc. - Caliper Life Sciences - Freeslate - Gilson - Hamilton Company - Hitachi High-Technologies Corp. - HTI bio-X GmbH - InnovaSystems Inc. - J-Kem Scientific - Labcyte - Labotix Automation - Lab Services BV - Peak Analysis and Automation - PerkinElmer Life and Analytical Sciences Inc. - F. Hoffmann-La Roche Ltd. - RTS Life Science - Sotax - SSi Robotics - TAP Biosystems - Tecan Group Ltd. - Thermo Fisher Scientific Inc Key Topics Covered: 1.0 EXECUTIVE SUMMARY 2.0 INTRODUCTION 3.0 PARTNERSHIPS 4.0 MARKET DEVELOPMENTS 5.0 MARKETS 6.0 CORPORATE PROFILES For more information visit http://www.researchandmarkets.com/research/bd...automation
A: 42.71 (-0.18), BRKS: 11.23 (-0.04), PKI: 51.69 (-0.02)
PerkinElmer To Present at Baird 2015 Growth Stock Conference
Business Wire - Mon Apr 20, 3:05PM CDT
PerkinElmer, Inc. (NYSE: PKI), a global leader focused on improving the health and safety of people and the environment, today announced that the Company will present at the Baird 2015 Growth Stock Conference on Thursday, May 7, 2015 at 1:15 p.m. CT at the Four Seasons Hotel in Chicago.
PKI: 51.69 (-0.02)
Week In Review: Menarini And Lummy Announce Novel Drug In-Licensings For China
ChinaBio Today - at Seeking Alpha - Sat Apr 18, 12:07PM CDT
Deals and Financings Menarini of Italy in-licensed China and Asia-Pacific rights to a proposed liver cancer treatment developed by Germany's 4SC AG for $100 million in upfront and milestone payments. Resminostat, 4SC's lead oncology compound, is an...
BSX: 18.41 (+0.10), ARGS: 8.48 (-0.11), PKI: 51.69 (-0.02)
ADME-Toxicology Testing (In-Vivo, & In-Vitro) Market - Global Strategic Business Report 2015
M2 - Fri Apr 17, 4:49AM CDT
Research and Markets (http://www.researchandmarkets.com/research/7ktnx6/admetoxicology) has announced the addition of the "ADME-Toxicology Testing - Global Strategic Business Report" report to their offering. This report analyzes the worldwide markets for ADME-Toxicology Testing in US$ Million by the following Segments: Toxicology Testing (In-Vivo, & In-Vitro), and ADME Testing. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, and Rest of World. Annual estimates and forecasts are provided for the period 2014 through 2020. Also, a five-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. The report profiles 73 companies including many key and niche players such as: - ACEA Biosciences, Inc. (US) - ADMEcell, Inc. (US) - Agilent Technologies, Inc. (US) - Albany Molecular Research, Inc. (US) - Bayer Technology Services GmbH (Germany) - Beckman Coulter, Inc. (US) - BioreclamationIVT, LLC (US) - Cambridge Cell Networks Ltd. (UK) - Cerep SA (France) - CompuDrug International, Inc. (US) - Cyprotex PLC. (UK) - CeeTox, Inc. (US) - Dassault Syst?mes (France) - Entelos, Inc. (US) - Elsevier B.V. (The Netherlands) - Eurofins ADME BIOANALYSES SAS (France) - Galapagos NV (Belgium) - Molecular Discovery Ltd. (UK) - MultiCASE, Inc. (US) - Optivia Biotechnology (US) - PerkinElmer, Inc. (US) - Pharmaron, Inc. (US) - Promega Corporation (US) - Qualyst, Inc. (US) - Simulations Plus, Inc. (US) - Taconic Farms, Inc. (US) - Takara Bio Europe AB (Sweden) - Tecan Group Ltd. (Switzerland) - Thermo Fisher Scientific, Inc. (US) - Xceleron, Inc. (US) Key Topics Covered: 1. OUTLOOK 2. INDUSTRY OVERVIEW 3. MARKET DYNAMICS 4. DRUG DISCOVERY & DEVELOPMENT 5. PRODUCT OVERVIEW 6. PRODUCT INNOVATIONS/INTRODUCTIONS 7. RECENT INDUSTRY ACTIVITY 8. FOCUS ON SELECT PLAYERS 9. GLOBAL MARKET PERSPECTIVE Total Companies Profiled: 73 (including Divisions/Subsidiaries - 81) - The United States (48) - Canada (2) - Japan (2) - Europe (24) - - France (4) - - Germany (3) - - The United Kingdom (7) - - Spain (1) - - Rest of Europe (9) - Asia-Pacific (Excluding Japan) (5) For more information visit http://www.researchandmarkets.com/research/7k...toxicology
SLP: 5.84 (-0.02), A: 42.71 (-0.18), AMRI: 18.48 (-0.19), PKI: 51.69 (-0.02)
Shares of PKI Up 17.2% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Wed Apr 15, 9:31AM CDT
SmarTrend identified an Uptrend for PerkinElmer (NYSE KI) on December 19th, 2014 at $43.81. In approximately 4 months, PerkinElmer has returned 17.25% as of today's recent price of $51.36.
PKI: 51.69 (-0.02)
Global Air Quality Monitoring Equipment Market Report 2015-2019
M2 - Mon Apr 13, 6:41AM CDT
Research and Markets (http://www.researchandmarkets.com/research/wnnst2/air_quality) has announced the addition of the "Air Quality Monitoring Equipment Market by Product, End User, Component - Global Forecast to 2019" report to their offering. The global air quality monitoring equipment market is expected to reach $6,147.77 million by 2019 from $3,968.25 million in 2014, at a CAGR of 9.15% during the forecast period of 2014 to 2019. The report provides a granular understanding of the air quality monitoring equipment market. This report segments the global market on the basis of products, end users, components, technology and geography. The end user segments included in this report are commercial and residential users, government and academia, pharmaceutical industry, power plants, refining, and oil and gas, and other industries. The product segments included in this report are indoor air quality monitors and outdoor air quality monitors. The sub-segments of the indoor air quality monitors included in this report are indoor fixed monitors and indoor portable monitors. The sub-segments of the outdoor air quality monitors segment included in this report are AQM stations, dust & particulate monitors, outdoor fixed monitors, and outdoor portable monitors. The air quality monitoring equipment market is segmented on the basis of technology into continuous monitoring, intermittent monitoring, manual monitoring, and passive monitoring. On the basis of components the market is categorized into biological parameters, chemical parameters, and physical parameters. The geographic segments included in this report are Asia, Europe, North America, and the Rest of the World (RoW). The North American segment includes Canada, and the U.S. The report maps each application, technology, component, and product segment in 6 geographic and regional segments. The major players in the air quality monitoring equipment market include 3M Company (U.S.), Aeroqual, Ltd. (New Zealand), Cerex Monitoring Solutions, LLC (U.S.), Honeywell International, Inc. (U.S.), HORIBA, Ltd. (Japan), PerkinElmer, Inc. (U.S.), Teledyne Technologies, Inc. (U.S.), Thermo Fisher Scientific Corporation (U.S.), Tisch International (U.S.), and TSI, Inc. (U.S.). Key Topics Covered: 1 Introduction 2 Research Methodology 3 Executive Summary 4 Premium Insights 5 Market Overview 6 Industry Insights 7 Air Quality Monitoring Equipment Market, By Product 8 Air Quality Monitoring Equipment Market, By End User 9 Air Quality Monitoring Equipment Market, By Component 10 Air Quality Monitoring Equipment Market, By Technology 11 Geographic Analysis 12 Competitive Landscape 13 Company Profiles For more information visit http://www.researchandmarkets.com/research/wn...ir_quality
TDY: 109.69 (+0.48), HON: 102.19 (+0.86), PKI: 51.69 (-0.02)
Comparing America's Next 3 Medical Laboratories And Research Companies
Joseph Cafariello - at Seeking Alpha - Wed Apr 08, 10:44AM CDT
Q: 66.45 (-0.25), LH: 126.26 (+0.35), PKI: 51.69 (-0.02)
Global Nanotechnology in Medical Devices Market 2015-2019
M2 - Wed Apr 08, 5:48AM CDT
Research and Markets (http://www.researchandmarkets.com/research/hzck8j/nanotechnology_in) has announced the addition of the "Nanotechnology in Medical Devices Market by Product (Biochip, Implant Materials, Medical Textiles, Wound Dressing, Cardiac Rhythm Management Devices, Hearing Aid), Application (Therapeutic, Diagnostic, Research) - Global Forecast to 2019" report to their offering. The Nanotechnology in Medical Devices Market is was valued at around $5 Billion in 2014 and expected to reach around $8.5 Billion by 2019 with a CAGR of around 11-12% during the forecast period 2014 - 2019 This market is mainly driven by the rising aging population, increasing R&D expenditure, and international research collaborations. However, high costs of nanotechnology-based medical devices and time-consuming product approval processes are inhibiting the growth of this market to a certain extent. The global nanotechnology-based medical devices market is classified on the basis of products and applications. On the basis of products, the market is categorized into biochips, implantable materials, medical textile and wound dressing, active implantable devices, and others. The implantable materials segment is bifurcated into dental filling materials and bone restorative materials. The active implantable devices segment is bifurcated into cardiac rhythm management devices, hearing aid devices, and retinal implants. On the basis of applications, the nanotechnology-based medical devices market is categorized into therapeutic applications, diagnostics applications, and research applications. In 2013, the active implantable devices segment accounted for the largest share of the market. The nanotechnology-based active implantable devices market is primarily driven by the growing incidence of age-related diseases, availability of insurance coverage and reimbursement for medical devices, presence of well-structured distribution channels, and growing out-of-pocket healthcare spending. North America represented the largest regional market in 2014, followed by Europe, Asia-Pacific, and RoW. The Asia-Pacific region represents the fastest-growing market for the nanotechnology-based medical devices market, primarily due to the rising aging population, increasing international research collaborations, increasing R&D expenditure, and growth in the overall healthcare industry. In addition, increased awareness regarding nanotechnology-based devices in countries such as China, Taiwan, and Japan are further driving the market in these regions. Major players in the global nanotechnology-based medical devices market are Stryker Corporation (U.S.), 3M Company (U.S.), St. Jude Medical, Inc. (U.S.), Affymetrix, Inc. (U.S.), PerkinElmer, Inc. (U.S.), Starkey Hearing Technologies (U.S.), and Smith & Nephew plc (U.K.). Key Topics Covered: 1 Introduction 2 Research Methodology 3 Executive Summary 4 Premium Insights 5 Market Overview 6 Industry Trends 7 Global Nanotechnology-Based Medical Devices Market, By Product 8 Nanotechnology-Based Medical Devices Market, By Application 9 Global Nanotechnology-Based Medical Devices Market, By Region 10 Competitive Landscape 11 Company Profiles - 3M Company - AAP Implantate AG - Affymetrix, Inc. - Dentsply International - Mitsui Chemicals, Inc. - Perkinelmer, Inc. - ST. Jude Medical, Inc. - Smith & Nephew PLC - Starkey Hearing Technologies - Stryker Corporation For more information visit http://www.researchandmarkets.com/research/hz...hnology_in
SNN: 35.15 (+0.37), MMM: 164.67 (+0.67), STJ: 73.55 (+4.43), PKI: 51.69 (-0.02), AFFX: 12.57 (-0.13), SYK: 96.45 (+1.74)
Global Laboratory Information Management System (LIMS) Market 2015-2019
M2 - Wed Apr 08, 4:33AM CDT
Research and Markets (http://www.researchandmarkets.com/research/tjkw4k/global_laboratory) has announced the addition of the "Global Laboratory Information Management System (LIMS) Market 2015-2019" report to their offering. The Global LIMS market to grow at a CAGR of 6.04% over the period 2014-2019 LIMS is the information management system specifically designed for medical and industrial-related laboratories. The solution helps scientists in tracking samples and transmitting data to professionals. LIMS offers a way of automating the laboratory, and saves time and improves the quality of data. This report covers the present scenario and the growth prospects of the Global LIMS market for the period 2015-2019. To calculate the market size, the report considers revenue generated from the sale of LIMS including clinical laboratory systems and drug discovery laboratory systems. The report also provides the revenue generated from on-premises and cloud deployment models. One key trend emerging in this market is the increased usage of cloud-based LIMS by laboratories. Cloud computing is an emerging trend, and it continues to develop because of the cost-advantage and ease of access it offers. According to the report, one key factor driving the market is the need to comply with government regulations. The governments of many countries have enforced regulations on every industry to improve security and provide better products to the market. LIMS helps laboratory professionals to understand and follow government regulations. Further, the report states that the high cost of implementing LIMS is one of the major challenges that the market faces. The procurement of raw materials for LIMS along with all required instruments is expensive and may not be affordable for SMEs. In addition, the training cost and the cost of maintenance and updates after implementation enhance the cost of LIMS. Benefits of using LIMS are: - Enhancement in efficiency of business - Improvement in quality of reports - Improvement in quality of data - Automated quality control and customer reports - Easy accessibility to data - Storage of data in database The report also provides a detailed analysis of the following end-user sectors that use LIMS software: - Academic Research - Food and Beverages - Healthcare - Pharma and Biotech - Petrochemicals - Others: This include Manufacturing, Material Testing, and Personal Care Key Vendors - LabVanatge Solutions - LabWare - STARLIMS - ThermoFisher Scientific Other Prominent Vendors - AgileBio - Agilent Technologies - Autoscribe - BiochemLab Solutions - BioData - Biomatters - ChemWare - CloudLIMS - LabArchives - labfolder - LabLynx - LABTrack - PerkinElmer - Scilligence - TerraSystems For more information visit http://www.researchandmarkets.com/research/tj...laboratory
A: 42.71 (-0.18), PKI: 51.69 (-0.02)
Uptrend Call Working As PerkinElmer Stock Rises 15.4% (PKI)
Comtex SmarTrend(R) - Tue Apr 07, 5:31PM CDT
SmarTrend identified an Uptrend for PerkinElmer (NYSE KI) on December 19th, 2014 at $43.81. In approximately 4 months, PerkinElmer has returned 15.40% as of today's recent price of $50.55.
PKI: 51.69 (-0.02)
PerkinElmer to Hold Earnings Call on Thursday, April 30, 2015
Business Wire - Mon Apr 06, 3:05PM CDT
PerkinElmer, Inc., (NYSE KI) a global leader focused on improving the health and safety of people and the environment, today announced that on Thursday, April 30, 2015, after market close, the Company will release first quarter 2015 results. The Company will also host a conference call the same day at 5:00 p.m. ET to discuss these results. Robert F. Friel, chairman and chief executive officer, and Andy Wilson, senior vice president and chief financial officer, will host the conference call.
PKI: 51.69 (-0.02)
Jeffrey D. Capello Appointed to Flex Pharma's Board of Directors
Business Wire - Mon Apr 06, 7:30AM CDT
Click to Tweet this News
BSX: 18.41 (+0.10), JNJ: 100.43 (+0.13), CG: 29.75 (+0.36), OVAS: 29.85 (-0.24), FLKS: 22.84 (-1.33), PKI: 51.69 (-0.02)
Applied BioCode Licenses Barcoded Magnetic Bead Technology and BioCode MDx 3000 High Throughput MDx System to PerkinElmer for Asian Infectious Disease Markets
Business Wire - Tue Mar 31, 1:11PM CDT
Applied BioCode announced today that it has expanded its existing License and Supply Agreement for its multiplex Barcoded Magnetic Bead (BMB) technology with PerkinElmer. The non-exclusive license from Applied BioCode provides PerkinElmer with access to Applied BioCode's 4,096-plex BMB patents and BioCode MDx 3000 high throughput system for the Asian markets. PerkinElmer will develop market specific multiplexed molecular diagnostics infectious disease assays for the BioCode MDx 3000 system and distribute these products into select markets in Asia.
PKI: 51.69 (-0.02)
After Yesterday's Rally of 1.15% Shares Could Potentially Pullback
Comtex SmarTrend(R) - Fri Mar 27, 5:34PM CDT
PerkinElmer (NYSE KI) traded in a range yesterday that spanned from a low of $50.44 to a high of $51.17. Yesterday, the shares gained 1.1%, which took the trading range above the 3-day high of $50.83 on volume of 941,000 shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
PKI: 51.69 (-0.02)
PerkinElmer Up 15.9% Since SmarTrend Uptrend Call (PKI)
Comtex SmarTrend(R) - Fri Mar 27, 10:06AM CDT
SmarTrend identified an Uptrend for PerkinElmer (NYSE KI) on December 19th, 2014 at $43.81. In approximately 3 months, PerkinElmer has returned 15.85% as of today's recent price of $50.75.
PKI: 51.69 (-0.02)
PerkinElmer Set to Possibly Pullback After Yesterday's Rally of 1.14%
Comtex SmarTrend(R) - Thu Mar 19, 5:03PM CDT
PerkinElmer (NYSE KI) traded in a range yesterday that spanned from a low of $48.78 to a high of $49.96. Yesterday, the shares gained 1.1%, which took the trading range above the 3-day high of $49.30 on volume of 1.1 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
PKI: 51.69 (-0.02)
18.0% Return Seen to Date on SmarTrend PerkinElmer Call (PKI)
Comtex SmarTrend(R) - Wed Apr 22, 9:59AM CDT
SmarTrend identified an Uptrend for PerkinElmer (NYSE
KI) on December 19th, 2014 at $43.81. In approximately 4 months, PerkinElmer has returned 18.02% as of today's recent price of $51.70. PKI: 51.69 (-0.02)
My Top Life Sciences Tools And Services Stocks For 2015
Stan Stafford - at Seeking Alpha - Wed Apr 22, 12:57AM CDT
PRXL: 67.12 (-0.42), Q: 66.45 (-0.25), CBM: 42.07 (-0.65), TMO: 130.69 (-3.75), NEO: 4.83 (-0.04), ILMN: 190.04 (-9.27), LMNX: 16.34 (-0.01), CRL: 78.06 (-0.53), PKI: 51.69 (-0.02), ICLR: 69.24 (+1.28), MTD: 324.14 (+0.66)
Lab Automation Markets: Key Companies, Forecasts and Trends, 2015 Edition - Sample Transport, Specimen Handling, Plate Readers, Storage & Retrieval, Robotics, LIMS
M2 - Tue Apr 21, 4:04AM CDT
Research and Markets (http://www.researchandmarkets.com/research/bdct5v/lab_automation) has announced the addition of the "Lab Automation Markets, 4th Edition (Systems [Sample Transport, Specimen Handling, Plate Readers, Storage & Retrieval, Robotics, LIMS], Key Companies, Forecasts and Trends)" report to their offering. Automation is influencing health care, especially in clinical diagnostic and drug company laboratories where systems are improving work flow and adding speed and efficiency. Over the years, many laboratories in North America, Europe and elsewhere have installed fully functional automation systems, as well as individual automated systems. Lab Automation Markets, 4th Edition, analyzes the current and potential world markets for medical laboratory automation systems and equipment - both for the clinical diagnostics lab and the drug discovery and research laboratory. This report generally offers forecasts future growth to 2017. Market segments covered include: - Sample transport systems - Specimen and liquid handling systems - Storage and retrieval systems - Work stations - Plate readers - Robotics - Dissolution testing - Laboratory information management systems This report gives insight into issues facing the industry and also reviews the nature and the direction of research and trends in automation equipment, including: - Miniaturization - Connectivity - Consolidation - Integration - Analytical intelligence - Robotics As automation companies seek to find new market opportunities and increase their sales, several of these firms have inked partnership agreements or have established other types of collaborative arrangements with in vitro diagnostic (IVD) companies. For automation suppliers, these arrangements can lead to sales that might otherwise not been achieved without the attraction of the IVD systems. Partnerships discussed include: - Roche-PVT - Pfizer-UCB - BD-Kiestra - Tecan-Recipe - Singulex-Tecan - Copan-MetaSystems - Quanterix-Stratec - Beckman Coulter Life Sciences-New England Biolabs - Beckman Coulter-IRIS Diagnostics - Beckman Coulter Life Sciences-Illumina - Brooks Automation-FluidX - Molecular Devices-Roche - bioM?rieux-Copan - Roche-Hitachi Market forecasts are based on an examination of current market conditions and on investigations into the development of new products by key companies. The report profiles companies involved in developing and marketing medical laboratory automation systems and equipment: - Abbott Diagnostics - Accel Biotech - Agilent Technologies Inc. - Ai Scientific - Analytik Jena - Andrew Alliance - Apricot Designs - Astech Projects Ltd. - Aurora Biotechnologies - Brooks Automation Inc. - Caliper Life Sciences - Freeslate - Gilson - Hamilton Company - Hitachi High-Technologies Corp. - HTI bio-X GmbH - InnovaSystems Inc. - J-Kem Scientific - Labcyte - Labotix Automation - Lab Services BV - Peak Analysis and Automation - PerkinElmer Life and Analytical Sciences Inc. - F. Hoffmann-La Roche Ltd. - RTS Life Science - Sotax - SSi Robotics - TAP Biosystems - Tecan Group Ltd. - Thermo Fisher Scientific Inc Key Topics Covered: 1.0 EXECUTIVE SUMMARY 2.0 INTRODUCTION 3.0 PARTNERSHIPS 4.0 MARKET DEVELOPMENTS 5.0 MARKETS 6.0 CORPORATE PROFILES For more information visit http://www.researchandmarkets.com/research/bd...automation
A: 42.71 (-0.18), BRKS: 11.23 (-0.04), PKI: 51.69 (-0.02)
PerkinElmer To Present at Baird 2015 Growth Stock Conference
Business Wire - Mon Apr 20, 3:05PM CDT
PerkinElmer, Inc. (NYSE: PKI), a global leader focused on improving the health and safety of people and the environment, today announced that the Company will present at the Baird 2015 Growth Stock Conference on Thursday, May 7, 2015 at 1:15 p.m. CT at the Four Seasons Hotel in Chicago.
PKI: 51.69 (-0.02)
Week In Review: Menarini And Lummy Announce Novel Drug In-Licensings For China
ChinaBio Today - at Seeking Alpha - Sat Apr 18, 12:07PM CDT
Deals and Financings Menarini of Italy in-licensed China and Asia-Pacific rights to a proposed liver cancer treatment developed by Germany's 4SC AG for $100 million in upfront and milestone payments. Resminostat, 4SC's lead oncology compound, is an...
BSX: 18.41 (+0.10), ARGS: 8.48 (-0.11), PKI: 51.69 (-0.02)
ADME-Toxicology Testing (In-Vivo, & In-Vitro) Market - Global Strategic Business Report 2015
M2 - Fri Apr 17, 4:49AM CDT
Research and Markets (http://www.researchandmarkets.com/research/7ktnx6/admetoxicology) has announced the addition of the "ADME-Toxicology Testing - Global Strategic Business Report" report to their offering. This report analyzes the worldwide markets for ADME-Toxicology Testing in US$ Million by the following Segments: Toxicology Testing (In-Vivo, & In-Vitro), and ADME Testing. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, and Rest of World. Annual estimates and forecasts are provided for the period 2014 through 2020. Also, a five-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. The report profiles 73 companies including many key and niche players such as: - ACEA Biosciences, Inc. (US) - ADMEcell, Inc. (US) - Agilent Technologies, Inc. (US) - Albany Molecular Research, Inc. (US) - Bayer Technology Services GmbH (Germany) - Beckman Coulter, Inc. (US) - BioreclamationIVT, LLC (US) - Cambridge Cell Networks Ltd. (UK) - Cerep SA (France) - CompuDrug International, Inc. (US) - Cyprotex PLC. (UK) - CeeTox, Inc. (US) - Dassault Syst?mes (France) - Entelos, Inc. (US) - Elsevier B.V. (The Netherlands) - Eurofins ADME BIOANALYSES SAS (France) - Galapagos NV (Belgium) - Molecular Discovery Ltd. (UK) - MultiCASE, Inc. (US) - Optivia Biotechnology (US) - PerkinElmer, Inc. (US) - Pharmaron, Inc. (US) - Promega Corporation (US) - Qualyst, Inc. (US) - Simulations Plus, Inc. (US) - Taconic Farms, Inc. (US) - Takara Bio Europe AB (Sweden) - Tecan Group Ltd. (Switzerland) - Thermo Fisher Scientific, Inc. (US) - Xceleron, Inc. (US) Key Topics Covered: 1. OUTLOOK 2. INDUSTRY OVERVIEW 3. MARKET DYNAMICS 4. DRUG DISCOVERY & DEVELOPMENT 5. PRODUCT OVERVIEW 6. PRODUCT INNOVATIONS/INTRODUCTIONS 7. RECENT INDUSTRY ACTIVITY 8. FOCUS ON SELECT PLAYERS 9. GLOBAL MARKET PERSPECTIVE Total Companies Profiled: 73 (including Divisions/Subsidiaries - 81) - The United States (48) - Canada (2) - Japan (2) - Europe (24) - - France (4) - - Germany (3) - - The United Kingdom (7) - - Spain (1) - - Rest of Europe (9) - Asia-Pacific (Excluding Japan) (5) For more information visit http://www.researchandmarkets.com/research/7k...toxicology
SLP: 5.84 (-0.02), A: 42.71 (-0.18), AMRI: 18.48 (-0.19), PKI: 51.69 (-0.02)
Shares of PKI Up 17.2% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Wed Apr 15, 9:31AM CDT
SmarTrend identified an Uptrend for PerkinElmer (NYSE
KI) on December 19th, 2014 at $43.81. In approximately 4 months, PerkinElmer has returned 17.25% as of today's recent price of $51.36. PKI: 51.69 (-0.02)
Global Air Quality Monitoring Equipment Market Report 2015-2019
M2 - Mon Apr 13, 6:41AM CDT
Research and Markets (http://www.researchandmarkets.com/research/wnnst2/air_quality) has announced the addition of the "Air Quality Monitoring Equipment Market by Product, End User, Component - Global Forecast to 2019" report to their offering. The global air quality monitoring equipment market is expected to reach $6,147.77 million by 2019 from $3,968.25 million in 2014, at a CAGR of 9.15% during the forecast period of 2014 to 2019. The report provides a granular understanding of the air quality monitoring equipment market. This report segments the global market on the basis of products, end users, components, technology and geography. The end user segments included in this report are commercial and residential users, government and academia, pharmaceutical industry, power plants, refining, and oil and gas, and other industries. The product segments included in this report are indoor air quality monitors and outdoor air quality monitors. The sub-segments of the indoor air quality monitors included in this report are indoor fixed monitors and indoor portable monitors. The sub-segments of the outdoor air quality monitors segment included in this report are AQM stations, dust & particulate monitors, outdoor fixed monitors, and outdoor portable monitors. The air quality monitoring equipment market is segmented on the basis of technology into continuous monitoring, intermittent monitoring, manual monitoring, and passive monitoring. On the basis of components the market is categorized into biological parameters, chemical parameters, and physical parameters. The geographic segments included in this report are Asia, Europe, North America, and the Rest of the World (RoW). The North American segment includes Canada, and the U.S. The report maps each application, technology, component, and product segment in 6 geographic and regional segments. The major players in the air quality monitoring equipment market include 3M Company (U.S.), Aeroqual, Ltd. (New Zealand), Cerex Monitoring Solutions, LLC (U.S.), Honeywell International, Inc. (U.S.), HORIBA, Ltd. (Japan), PerkinElmer, Inc. (U.S.), Teledyne Technologies, Inc. (U.S.), Thermo Fisher Scientific Corporation (U.S.), Tisch International (U.S.), and TSI, Inc. (U.S.). Key Topics Covered: 1 Introduction 2 Research Methodology 3 Executive Summary 4 Premium Insights 5 Market Overview 6 Industry Insights 7 Air Quality Monitoring Equipment Market, By Product 8 Air Quality Monitoring Equipment Market, By End User 9 Air Quality Monitoring Equipment Market, By Component 10 Air Quality Monitoring Equipment Market, By Technology 11 Geographic Analysis 12 Competitive Landscape 13 Company Profiles For more information visit http://www.researchandmarkets.com/research/wn...ir_quality
TDY: 109.69 (+0.48), HON: 102.19 (+0.86), PKI: 51.69 (-0.02)
Comparing America's Next 3 Medical Laboratories And Research Companies
Joseph Cafariello - at Seeking Alpha - Wed Apr 08, 10:44AM CDT
Q: 66.45 (-0.25), LH: 126.26 (+0.35), PKI: 51.69 (-0.02)
Global Nanotechnology in Medical Devices Market 2015-2019
M2 - Wed Apr 08, 5:48AM CDT
Research and Markets (http://www.researchandmarkets.com/research/hzck8j/nanotechnology_in) has announced the addition of the "Nanotechnology in Medical Devices Market by Product (Biochip, Implant Materials, Medical Textiles, Wound Dressing, Cardiac Rhythm Management Devices, Hearing Aid), Application (Therapeutic, Diagnostic, Research) - Global Forecast to 2019" report to their offering. The Nanotechnology in Medical Devices Market is was valued at around $5 Billion in 2014 and expected to reach around $8.5 Billion by 2019 with a CAGR of around 11-12% during the forecast period 2014 - 2019 This market is mainly driven by the rising aging population, increasing R&D expenditure, and international research collaborations. However, high costs of nanotechnology-based medical devices and time-consuming product approval processes are inhibiting the growth of this market to a certain extent. The global nanotechnology-based medical devices market is classified on the basis of products and applications. On the basis of products, the market is categorized into biochips, implantable materials, medical textile and wound dressing, active implantable devices, and others. The implantable materials segment is bifurcated into dental filling materials and bone restorative materials. The active implantable devices segment is bifurcated into cardiac rhythm management devices, hearing aid devices, and retinal implants. On the basis of applications, the nanotechnology-based medical devices market is categorized into therapeutic applications, diagnostics applications, and research applications. In 2013, the active implantable devices segment accounted for the largest share of the market. The nanotechnology-based active implantable devices market is primarily driven by the growing incidence of age-related diseases, availability of insurance coverage and reimbursement for medical devices, presence of well-structured distribution channels, and growing out-of-pocket healthcare spending. North America represented the largest regional market in 2014, followed by Europe, Asia-Pacific, and RoW. The Asia-Pacific region represents the fastest-growing market for the nanotechnology-based medical devices market, primarily due to the rising aging population, increasing international research collaborations, increasing R&D expenditure, and growth in the overall healthcare industry. In addition, increased awareness regarding nanotechnology-based devices in countries such as China, Taiwan, and Japan are further driving the market in these regions. Major players in the global nanotechnology-based medical devices market are Stryker Corporation (U.S.), 3M Company (U.S.), St. Jude Medical, Inc. (U.S.), Affymetrix, Inc. (U.S.), PerkinElmer, Inc. (U.S.), Starkey Hearing Technologies (U.S.), and Smith & Nephew plc (U.K.). Key Topics Covered: 1 Introduction 2 Research Methodology 3 Executive Summary 4 Premium Insights 5 Market Overview 6 Industry Trends 7 Global Nanotechnology-Based Medical Devices Market, By Product 8 Nanotechnology-Based Medical Devices Market, By Application 9 Global Nanotechnology-Based Medical Devices Market, By Region 10 Competitive Landscape 11 Company Profiles - 3M Company - AAP Implantate AG - Affymetrix, Inc. - Dentsply International - Mitsui Chemicals, Inc. - Perkinelmer, Inc. - ST. Jude Medical, Inc. - Smith & Nephew PLC - Starkey Hearing Technologies - Stryker Corporation For more information visit http://www.researchandmarkets.com/research/hz...hnology_in
SNN: 35.15 (+0.37), MMM: 164.67 (+0.67), STJ: 73.55 (+4.43), PKI: 51.69 (-0.02), AFFX: 12.57 (-0.13), SYK: 96.45 (+1.74)
Global Laboratory Information Management System (LIMS) Market 2015-2019
M2 - Wed Apr 08, 4:33AM CDT
Research and Markets (http://www.researchandmarkets.com/research/tjkw4k/global_laboratory) has announced the addition of the "Global Laboratory Information Management System (LIMS) Market 2015-2019" report to their offering. The Global LIMS market to grow at a CAGR of 6.04% over the period 2014-2019 LIMS is the information management system specifically designed for medical and industrial-related laboratories. The solution helps scientists in tracking samples and transmitting data to professionals. LIMS offers a way of automating the laboratory, and saves time and improves the quality of data. This report covers the present scenario and the growth prospects of the Global LIMS market for the period 2015-2019. To calculate the market size, the report considers revenue generated from the sale of LIMS including clinical laboratory systems and drug discovery laboratory systems. The report also provides the revenue generated from on-premises and cloud deployment models. One key trend emerging in this market is the increased usage of cloud-based LIMS by laboratories. Cloud computing is an emerging trend, and it continues to develop because of the cost-advantage and ease of access it offers. According to the report, one key factor driving the market is the need to comply with government regulations. The governments of many countries have enforced regulations on every industry to improve security and provide better products to the market. LIMS helps laboratory professionals to understand and follow government regulations. Further, the report states that the high cost of implementing LIMS is one of the major challenges that the market faces. The procurement of raw materials for LIMS along with all required instruments is expensive and may not be affordable for SMEs. In addition, the training cost and the cost of maintenance and updates after implementation enhance the cost of LIMS. Benefits of using LIMS are: - Enhancement in efficiency of business - Improvement in quality of reports - Improvement in quality of data - Automated quality control and customer reports - Easy accessibility to data - Storage of data in database The report also provides a detailed analysis of the following end-user sectors that use LIMS software: - Academic Research - Food and Beverages - Healthcare - Pharma and Biotech - Petrochemicals - Others: This include Manufacturing, Material Testing, and Personal Care Key Vendors - LabVanatge Solutions - LabWare - STARLIMS - ThermoFisher Scientific Other Prominent Vendors - AgileBio - Agilent Technologies - Autoscribe - BiochemLab Solutions - BioData - Biomatters - ChemWare - CloudLIMS - LabArchives - labfolder - LabLynx - LABTrack - PerkinElmer - Scilligence - TerraSystems For more information visit http://www.researchandmarkets.com/research/tj...laboratory
A: 42.71 (-0.18), PKI: 51.69 (-0.02)
Uptrend Call Working As PerkinElmer Stock Rises 15.4% (PKI)
Comtex SmarTrend(R) - Tue Apr 07, 5:31PM CDT
SmarTrend identified an Uptrend for PerkinElmer (NYSE
KI) on December 19th, 2014 at $43.81. In approximately 4 months, PerkinElmer has returned 15.40% as of today's recent price of $50.55. PKI: 51.69 (-0.02)
PerkinElmer to Hold Earnings Call on Thursday, April 30, 2015
Business Wire - Mon Apr 06, 3:05PM CDT
PerkinElmer, Inc., (NYSE
KI) a global leader focused on improving the health and safety of people and the environment, today announced that on Thursday, April 30, 2015, after market close, the Company will release first quarter 2015 results. The Company will also host a conference call the same day at 5:00 p.m. ET to discuss these results. Robert F. Friel, chairman and chief executive officer, and Andy Wilson, senior vice president and chief financial officer, will host the conference call. PKI: 51.69 (-0.02)
Jeffrey D. Capello Appointed to Flex Pharma's Board of Directors
Business Wire - Mon Apr 06, 7:30AM CDT
Click to Tweet this News
BSX: 18.41 (+0.10), JNJ: 100.43 (+0.13), CG: 29.75 (+0.36), OVAS: 29.85 (-0.24), FLKS: 22.84 (-1.33), PKI: 51.69 (-0.02)
Applied BioCode Licenses Barcoded Magnetic Bead Technology and BioCode MDx 3000 High Throughput MDx System to PerkinElmer for Asian Infectious Disease Markets
Business Wire - Tue Mar 31, 1:11PM CDT
Applied BioCode announced today that it has expanded its existing License and Supply Agreement for its multiplex Barcoded Magnetic Bead (BMB) technology with PerkinElmer. The non-exclusive license from Applied BioCode provides PerkinElmer with access to Applied BioCode's 4,096-plex BMB patents and BioCode MDx 3000 high throughput system for the Asian markets. PerkinElmer will develop market specific multiplexed molecular diagnostics infectious disease assays for the BioCode MDx 3000 system and distribute these products into select markets in Asia.
PKI: 51.69 (-0.02)
After Yesterday's Rally of 1.15% Shares Could Potentially Pullback
Comtex SmarTrend(R) - Fri Mar 27, 5:34PM CDT
PerkinElmer (NYSE
KI) traded in a range yesterday that spanned from a low of $50.44 to a high of $51.17. Yesterday, the shares gained 1.1%, which took the trading range above the 3-day high of $50.83 on volume of 941,000 shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious. PKI: 51.69 (-0.02)
PerkinElmer Up 15.9% Since SmarTrend Uptrend Call (PKI)
Comtex SmarTrend(R) - Fri Mar 27, 10:06AM CDT
SmarTrend identified an Uptrend for PerkinElmer (NYSE
KI) on December 19th, 2014 at $43.81. In approximately 3 months, PerkinElmer has returned 15.85% as of today's recent price of $50.75. PKI: 51.69 (-0.02)
PerkinElmer Set to Possibly Pullback After Yesterday's Rally of 1.14%
Comtex SmarTrend(R) - Thu Mar 19, 5:03PM CDT
PerkinElmer (NYSE
KI) traded in a range yesterday that spanned from a low of $48.78 to a high of $49.96. Yesterday, the shares gained 1.1%, which took the trading range above the 3-day high of $49.30 on volume of 1.1 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious. PKI: 51.69 (-0.02)
